Literature DB >> 1346283

Indomethacin and postprandial gallbladder emptying.

L J O'Donnell1, P Wilson, P Guest, S M Catnach, A McLean, J E Wickham, P D Fairclough.   

Abstract

Patients with gallstone disease commonly have impaired gallbladder emptying. To see whether non-steroidal anti-inflammatory drugs (NSAIDs) prevent gallstone formation by improving gallbladder emptying, we assessed the effect of indomethacin on postprandial emptying in healthy subjects and in patients with gallstone disease. Subjects received indomethacin 25 mg three times a day for a week and matching placebo for another week. Compared with placebo, indomethacin improved postprandial gallbladder emptying in all 7 patients with gallstone disease. This finding was not recorded in healthy subjects with normal gallbladders. The prevention of gallstone formation associated with ingestion of NSAIDs may be due mainly to a prokinetic effect on the gallbladder since there is no evidence to suggest that these drugs affect cholesterol crystal nucleation at ordinary therapeutic doses in man or animals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346283     DOI: 10.1016/0140-6736(92)91333-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Guidelines for management of patients with a short bowel.

Authors:  J Nightingale; J M Woodward
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 2.  Acute cholecystitis.

Authors:  Adrian A Indar; Ian J Beckingham
Journal:  BMJ       Date:  2002-09-21

3.  Effect of the nitric oxide donor, glyceryl trinitrate, on human gall bladder motility.

Authors:  R Greaves; J Miller; L O'Donnell; A McLean; M J Farthing
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

Review 4.  Gall stones and gall bladder motility.

Authors:  L J O'Donnell; P D Fairclough
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

5.  Cigarette smoking and parity as risk factors for the development of symptomatic gall bladder disease in women: results of the Royal College of General Practitioners' oral contraception study.

Authors:  F E Murray; R F Logan; P C Hannaford; C R Kay
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

6.  Differential effect of prostaglandins on gallstone-free and gallstone-containing human gallbladder.

Authors:  R R Greaves; L J O'Donnell; M J Farthing
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

7.  Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.

Authors:  Q W Xu; R B Scott; D T Tan; E A Shaffer
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 8.  Smooth muscle function and dysfunction in gallbladder disease.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gerard P vanBerge-Henegouwen
Journal:  Curr Gastroenterol Rep       Date:  2004-04

9.  The percutaneous rotary lithotrite: a new approach to the treatment of symptomatic cholecystolithiasis.

Authors:  A Gillams; J J Donald; R C Russell; A R Hatfield; W R Lees
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

10.  Indomethacin decreases viscosity of gallbladder bile in patients with cholesterol gallstone disease.

Authors:  C von Ritter; A Niemeyer; V Lange; W Möhrle; W O Richter; L von Meyer; H Brandl; R del Pozo; D Jüngst
Journal:  Clin Investig       Date:  1993-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.